Dr. Clay Siegall serves as the CEO of Seattle Genetics, a Seattle-based biotechnology company that he founded. The firm develops targeted therapy drugs that are meant for the disease types known not to have had considerable mortality improvements in the recent decades. From the University of Maryland, Dr. Siegall acquired a B.S. in Zoology and from George Washington University he holds a Ph.D. in genetics. Seattle Genetics has become a major power player in cancer research under Siegall’s leadership.
His inspiration to come up with Seattle Genetics was the interest that he has in medicine, the reason to fight diseases and the power of technology. In all these, he wanted to avert the fate of those who were facing death. Dr. Clay Siegall first developed an interest in the treatment of cancer while at the University of Maryland undertaking his studies in Zoology. He was also inspired by the quest for money to start up the venture.
At Seattle Genetics, making money is done in different ways. The first way is by selling their proprietary drugs. The revenues are also generated from production partnerships. Licensing of processes and technologies that they have developed also earns them great amounts of money. The firm has a dynamite of sales personnel that steer the business forward. In his words, Dr. Siegall asserts that it is hard work that makes him successful.
About Clay Siegall
Clay B. Siegall the CEO, the President as well as the Chairperson of the Board of Seattle Genetics, a firm that he co-founded in 1998. He built the company with the emphasis on rigorous research, drug development practices, scientific innovation and the passion for helping patients. Dr. Siegall has since steered the company to its current leadership position with tremendous achievements in targeted cancer therapy.
Between 1991 and 1997, he worked at the Bristol-Myers Squibb Pharmaceutical Research Institute after working with National Cancer Institute, National Institutes of Health between 1988 and 1991. Dr. Siegall is a Ph.D. holder in the field of genetics from George Washington University. He also has B.S. in Zoology that he holds from the University of Maryland.